Turn Therapeutics releases updated investor presentation; no specific details provided

Turn Therapeutics Inc.

Filed under Item 7.01 Regulation FD; presentation dated July 28, 2026.
Exhibit 99.1 is the investor presentation, but its content was not included in the filing text.
No financial results, pipeline updates, or material events disclosed in the 8-K body.
Ticker TTRX; presentation may contain corporate overview and strategy.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.